Clinical Research Malaysia (CRM) just launched its own Code of Conduct as guidance on how to react or act in the right & ethical manner for CRM’s employees. It comprises 5 Code of Conduct which include Respecting Others, Diligence & Integrity, Conducting Business, Protection of Company Properties & Assets and finally Community Around Us.
PETALING JAYA: Affordable Hepatitis C treatment will soon be available for patients once trials on generic drugs are completed.
The non-profit Drugs for Neglected Diseases initiative (DNDi), of which the Malaysian Health Ministry is a founding member, and Egyptian drug manufacturer Pharco Pharmaceuticals on Wednesday signed agreements covering clinical testing and scale-up of a Hepatitis C treatment regimen at a price of just under US$300 (RM1,166) at the International Liver Congress 2016 in Barcelona, Spain.
This is a fraction of the current US$40,000 treatment (RM155,442) using the original drug brand, according to a Health Ministry official.
Do you have any queries?